DE1484727U - - Google Patents

Info

Publication number
DE1484727U
DE1484727U DENDAT1484727D DE1484727DU DE1484727U DE 1484727 U DE1484727 U DE 1484727U DE NDAT1484727 D DENDAT1484727 D DE NDAT1484727D DE 1484727D U DE1484727D U DE 1484727DU DE 1484727 U DE1484727 U DE 1484727U
Authority
DE
Germany
Prior art keywords
ttt
mmt
tmt
iii
ttttt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1484727D
Other languages
German (de)
English (en)
Publication of DE1484727U publication Critical patent/DE1484727U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DENDAT1484727D Active DE1484727U (enExample)

Publications (1)

Publication Number Publication Date
DE1484727U true DE1484727U (enExample)

Family

ID=789914

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1484727D Active DE1484727U (enExample)

Country Status (1)

Country Link
DE (1) DE1484727U (enExample)

Similar Documents

Publication Publication Date Title
Yuan et al. Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
Keung et al. Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab
Oladipo et al. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue
Rini et al. Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma
Abraham et al. Clinical validation of a machine-learning–derived signature predictive of outcomes from first-line oxaliplatin-based chemotherapy in advanced colorectal cancer
Löffler et al. HAnd Suture Versus STApling for Closure of Loop Ileostomy (HASTA Trial): results of a multicenter randomized trial (DRKS00000040)
Cullen et al. The 111 study: a single-arm, phase 3 trial evaluating one cycle of bleomycin, etoposide, and cisplatin as adjuvant chemotherapy in high-risk, stage 1 nonseminomatous or combined germ cell tumours of the testis
US10416162B2 (en) Her2 diagnostic methods
Maity et al. Targeting the epidermal growth factor receptor with molecular degraders: state-of-the-art and future opportunities
DE1484727U (enExample)
CA2657324A1 (en) Methods for making cancer prognoses based on subcellular localization of biomarkers
CN102713606A (zh) 用于鉴定、评估、预防和治疗癌症的组合物、试剂盒和方法
US20250041296A1 (en) Novel dosing regimens for mdm2 inhibitors
Tejpar et al. Integrating biomarkers in colorectal cancer trials in the West and China
MacConmara et al. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma
ES2615265T3 (es) Métodos para determinar la probabilidad de supervivencia y para predecir la probabilidad de metástasis en el cáncer
Nishiwada et al. Clinical significance and functional role of adhesion G-protein-coupled receptors in human pancreatic ductal adenocarcinoma
Palleiko et al. Preoperative risk factors for anastomotic leak after esophagectomy with gastric reconstruction: A 6-year national surgical quality improvement (NSQIP) database analysis
Yao et al. How to reduce the early anastomotic complications of laparoscopic low anterior rectal resection? A video vignette.
Burns et al. The novel duodenal isolate streptococcus salivarius AGIRA0003 promotes barrier dysfunction and IgG responses in functional dyspepsia
Boroojerdi et al. Staining pattern of specific and cross‐reacting Melan‐A antibodies: A comparative study on 15,840 samples from 133 human tumor types
Kakegawa et al. A new technique for esophageal reconstruction by combined skin and muscle flaps after failure in primary colonic interposition.
Yuki et al. Laparoscopic Umbilical Resection of Urachal Remnants: An Optimal Surgical Method
US20190383820A1 (en) Detecting cancer stem cells using a glycan biomarker
Ieni et al. Changes in human epidermal growth factor receptor 2 status between primary breast/gastric carcinomas and synchronous metastatic lymph nodes: how can we explain them?